CLINICAL TRIALS PROFILE FOR NUCALA
✉ Email this page to a colleague
All Clinical Trials for NUCALA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | GlaxoSmithKline | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | Inner-City Asthma Consortium | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | Rho Federal Systems Division, Inc. | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NUCALA
Condition Name
Clinical Trial Locations for NUCALA
Trials by Country
Clinical Trial Progress for NUCALA
Clinical Trial Phase
Clinical Trial Sponsors for NUCALA
Sponsor Name